1417543-99-7Relevant academic research and scientific papers
Development of substituted N-[3-(3-methoxylphenyl)propyl] amides as MT 2-selective melatonin agonists: Improving metabolic stability
Hu, Yueqing,Zhu, Jing,Chan, King H.,Wong, Yung H.
, p. 547 - 552 (2013/02/25)
A series of novel and selective N-[3-(6-benzyloxy-3-methoxyphenyl)propyl] amides has recently been shown to possess sub-nanomolar range binding affinity to the type 2 melatonin receptor (MT2). Pharmacokinetics studies suggested that these compounds were subject to vigorous CYP450-mediated metabolism, resulting in a series of metabolites with significantly decreased or diminished binding affinities toward MT2 receptor. The ether bonds were found to be the major positions susceptible to metabolism. In this study, the benzyl ether bond was either removed or replaced with a carbon-carbon bond in an attempt to improve metabolic stability and enhance their resistance towards phase I oxidation. The synthesis, receptor binding affinity, intrinsic potency and metabolic stability of modified structures are reported in this article. By removal or replacement of metabolic labile ether linkerage with carbon linkers, a novel compound was identified with good potency and MT 2 selectivity, and with increased metabolic stability.
